Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

New research suggests that certain patients with low-risk thyroid cancer can safely forgo postoperative radioiodine ablation ...

A woman who was diagnosed with thyroid cancer at the age of 20 in 2022 was initially brushed off by doctors with her symptoms ...

Are we facing a new era in thyroid cancer therapy, in which the genetic basis of tumor development is used to tailor individual treatments?

Rather than tumor size alone, the American Thyroid Association’s risk stratification system should be used when assessing papillary thyroid microcarcinomas, according to data published in ...

Find out about the causes, symptoms, and treatment of papillary thyroid carcinoma, the most common type of caner to affect your thyroid gland.

Papillary thyroid cancer is the most common type of thyroid cancer and usually grows slowly. It can remain undetected for a long time.

Tevimbra is under clinical development by BeiGene and currently in Phase II for Anaplastic Thyroid Cancer. According to GlobalData, Phase II drugs for Anaplastic Thyroid Cancer have a 36% phase ...

A rare coexistence of intrathyroidal parathyroid gland and papillary thyroid carcinoma in a patient with MEN1 syndrome: a clinical, diagnostic, and surgical challenge.

An isthmusectomy is a surgical procedure to treat thyroid tumors in the center of your thyroid gland. It saves more of your thyroid tissue than other options.

Stage 4 thyroid cancer is the most serious; stage 1 is the least severe. The stage of someone's cancer is determined by the size and spread of cancer cells from a tumor's primary site, in this case, ...